chartexchange

HUTCHMED Highlights HMPL-A830 Pre-Clinical Data Presented at the 38th EORTC-NCI-AACR International Conference on Molecular Targets and Cancer Therapeutics

GlobeNewswire Inc. | Nov 18, 2026 7:00 PM EST

— A novel EGFR-directed ATTC  with a potent pan-KRAS payload designed to overcome resistance and systemic toxicity associated with EGFR/KRAS inhibition —

Read original article